tiprankstipranks
Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market

Dyne Therapeutics (DYN) Income Statement

Compare
308 Followers

Dyne Therapeutics Income Statement

Last quarter (Q4 2024), Dyne Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Dyne Therapeutics's net income was $-89.54M. See Dyne Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -2.46M$ -3.35M$ -1.09M$ -700.00K
Operating Expenses
$ 343.89M$ 242.16M$ 170.96M$ 150.03M$ 58.65M
Depreciation and Amortization
$ 0.00$ 2.46M$ 3.35M$ 1.09M$ 700.00K
EBITDA
$ -343.89M$ -233.48M$ -164.75M$ -148.20M$ -58.34M
Operating Income
$ -343.89M$ -242.16M$ -170.96M$ -150.03M$ -58.65M
Other Income/Expenses
$ 26.47M$ 6.22M$ 2.86M$ 734.00K$ -790.00K
Pretax Income
$ -317.42M$ -235.94M$ -168.10M$ -149.29M$ -59.44M
Net Income
$ -317.42M$ -235.94M$ -165.24M$ -149.28M$ -58.74M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.37$ -3.95$ -3.18$ -2.93$ -4.08
Diluted EPS
$ -3.37$ -3.95$ -3.18$ -2.93$ -4.08
Weighted Average Shares Outstanding
94.14M 59.68M 51.98M 50.90M 14.40M
Weighted Average Shares Outstanding (Diluted)
94.14M 59.68M 51.98M 50.90M 14.40M
Currency in USD

Dyne Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis